Clinical trial
An Observational, Prospective and Retrospective Clinical Study to Evaluate the Performance of QIAstat-Dx® Gastrointestinal Panel 2 During Normal Conditions of Use
NCT06745414 is registered in ClinicalTrials.gov with QIAGEN Gaithersburg, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational, Prospective and Retrospective Clinical Study to Evaluate the Performance of QIAstat-Dx® Gastrointestinal Panel 2 During Normal Conditions of Use
- Lead sponsor
- QIAGEN Gaithersburg, Inc
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 14, 2020
- Completion date
- December 31, 2021
- Enrollment
- 2,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal infection